A Phase I, Open Label, Fixed Sequence, Single Centre Study in Healthy Volunteers to Investigate the Effects of Repeated Oral Doses AZD9668 on the Pharmacokinetics and Pharmacodynamics of a Single Dose of Warfarin.

Trial Profile

A Phase I, Open Label, Fixed Sequence, Single Centre Study in Healthy Volunteers to Investigate the Effects of Repeated Oral Doses AZD9668 on the Pharmacokinetics and Pharmacodynamics of a Single Dose of Warfarin.

Withdrawn prior to enrolment
Phase of Trial: Phase I

Latest Information Update: 16 Oct 2015

At a glance

  • Drugs AZD 9668 (Primary) ; Warfarin (Primary)
  • Indications Bronchiectasis; Chronic obstructive pulmonary disease; Cystic fibrosis; Thrombosis
  • Focus Pharmacodynamics; Pharmacokinetics
  • Most Recent Events

    • 02 Dec 2010 Status changed from not yet recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
    • 09 Oct 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top